Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Add Yahoo as a preferred source to see more of our stories on Google. The Galleri test, which could be administered annually, detects DNA fragments shed by cancer cells in the bloodstream, often ...

An inexpensive version of the 'Galleri test,' a universal cancer blood test with extreme accuracy, is reportedly being developed by Hong Kong's Centre for Novostics as per Interesting Engineering. The ...

Add Yahoo as a preferred source to see more of our stories on Google. "No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat ...

One company has a big early lead in blood tests that detect cancer returning in survivors.

According to the American Cancer Society, by 2023, there will be around 609,360 deaths due to cancer. Of course, there are several things people can do to help eliminate causes of cancer, such as ...

Over the next few years, Galleri's sales could soar if the FDA approves it and receives more coverage from private insurance ...

Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the first quarter of 2026.

Many cancers do not exhibit symptoms and patients are unaware they have the disease until it has reached an advanced stage — but the Galleri test can change that. Galleri, which can detect cancer in ...

A pioneering blood test designed to screen for more than 50 types of cancer, currently being evaluated by the NHS, has correctly identified the disease in nearly two-thirds of cases it flagged. The ...